VIETRI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 2.287
EU - Europa 2.126
AS - Asia 1.307
SA - Sud America 240
AF - Africa 95
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.064
Nazione #
US - Stati Uniti d'America 2.227
IT - Italia 502
RU - Federazione Russa 493
SG - Singapore 411
GB - Regno Unito 316
CN - Cina 313
IE - Irlanda 247
BR - Brasile 209
VN - Vietnam 147
HK - Hong Kong 134
DE - Germania 127
SE - Svezia 114
FR - Francia 98
IN - India 61
FI - Finlandia 55
ZA - Sudafrica 55
BD - Bangladesh 44
UA - Ucraina 43
KR - Corea 38
CA - Canada 32
IQ - Iraq 30
ES - Italia 27
ID - Indonesia 25
JP - Giappone 24
NL - Olanda 23
MX - Messico 18
CZ - Repubblica Ceca 16
PL - Polonia 15
EG - Egitto 14
SA - Arabia Saudita 14
TR - Turchia 14
PK - Pakistan 13
BE - Belgio 11
AR - Argentina 8
AU - Australia 8
IR - Iran 8
AT - Austria 7
CI - Costa d'Avorio 7
HR - Croazia 7
BG - Bulgaria 6
EC - Ecuador 6
KE - Kenya 6
PY - Paraguay 5
AZ - Azerbaigian 4
CH - Svizzera 4
CM - Camerun 4
LT - Lituania 4
VE - Venezuela 4
CL - Cile 3
CO - Colombia 3
MA - Marocco 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
LV - Lettonia 2
MY - Malesia 2
PH - Filippine 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
YE - Yemen 1
Totale 6.064
Città #
Dallas 397
Southend 254
Dublin 243
Singapore 240
Ashburn 183
Moscow 160
Fairfield 147
Santa Clara 146
Chandler 130
Hong Kong 123
San Jose 122
Beijing 107
New York 65
Seattle 58
Siena 57
Wilmington 55
Woodbridge 55
Houston 54
Lastra a Signa 54
Milan 54
Johannesburg 50
Los Angeles 44
Helsinki 42
Cambridge 41
Ho Chi Minh City 40
Hefei 37
Munich 35
Princeton 34
Jacksonville 31
Lauterbourg 30
Hanoi 28
Ann Arbor 22
Council Bluffs 22
Seoul 22
São Paulo 21
Florence 20
Rome 19
Chicago 18
Gavirate 18
Redondo Beach 18
Shanghai 18
San Mateo 17
The Dalles 17
Tokyo 17
Buffalo 16
Fremont 16
Haiphong 16
Málaga 16
Nuremberg 16
Dearborn 15
Orem 15
Baghdad 12
Boardman 12
Brno 12
Warsaw 12
Frankfurt am Main 11
Hanover 11
Jeddah 11
Montreal 11
Comun Nuovo 10
Denver 10
London 10
Brooklyn 9
Chennai 9
Da Nang 9
Jakarta 9
Phoenix 9
San Diego 9
Bengaluru 8
Boston 8
Brescia 8
Mexico City 8
Paris 8
Toronto 8
Abidjan 7
Manchester 7
Padova 7
Piscataway 7
Portsmouth 7
Rio de Janeiro 7
Stockholm 7
Anagni 6
Atlanta 6
Belo Horizonte 6
Brussels 6
Dhaka 6
Lappeenranta 6
Mumbai 6
Turku 6
Agliana 5
Bologna 5
Cairo 5
Catanzaro 5
Curitiba 5
Düsseldorf 5
Istanbul 5
Jinan 5
Lucca 5
Naples 5
Orlando 5
Totale 3.851
Nome #
Serum amyloid A: a new biomarker in Idiopathic Pulmonary Fibrosis 419
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 418
An explainable model of host genetic interactions linked to COVID-19 severity 371
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 281
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 274
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 266
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 242
Serum amyloid A in patients with idiopathic pulmonary fibrosis 237
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 237
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 237
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 227
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 217
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 206
Serum amyloid A: A potential biomarker of lung disorders 203
Effects of rituximab therapy on B cell differentiation and depletion 193
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 179
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 173
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 164
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 158
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis 144
Serum Amyloid A in lung transplantation 139
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital. 128
Author reply 110
Correction to: BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases (Clinical and Experimental Medicine, (2020), 20, 2, (207-216), 10.1007/s10238-020-00608-5) 105
Lipid metabolism in interstitial lung diseases: serum amyloid A a new potential biomarker in idiopathic pulmonary fibrosis 81
Siero Amiloide A: nuovo potenziale biomarcatore di Fibrosi Polmonare Idiopatica. 70
Eterogeneità clinica e radiologica della sarcoidosi: case report di sarcoidosi sistemica con coinvolgimento osseo con aspetti di malignità. 56
Role of EBUS-TBNA in interstitial lung diseases: a case report of lymphangitis carcinomatosa. 55
A case report on expanding horizon of endobronchial ultrasound through esophagus 53
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 50
SAA and lipid metabolism in IPF 49
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 48
Biomarkers of Response to Nintedanib in IPF 47
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 46
FINDING BAL EOSINOPHILIA IN DESQUAMATIVE INTERSTITIAL PNEUMONIA 45
Atipical radiological NSIP pattern in GLILD: a case report 42
The thin line between sarcoidosis and cancer: can we consider PET as an oncologic screening tool in radiologically stable and asymptomatic sarcoidosis? 41
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 39
Sarcoidosis and Autoimmune Inflammatory Syndrome Induced by Adjuvants: a case report. 36
Chilotorace maligno: patogenesi e valore prognostico. 33
A challenging convergence of conditions in a patient with thalassemia major presenting with thymoma and lymphangioleiomyomatosis: a case report. 33
MYASTHENIA GRAVIS IN INTERSTITIAL LUNG DISEASE DUE TO RHEUMATOID ARTHRITIS: A RARE COMORBIDITY TO CONSIDER. 32
TH-2 INFLAMMATION: A COMMON PATHWAY BETWEEN UIP PATTERN PULMONARY FIBROSIS AND HYPEREOSINOPHILIC SYNDROME 21
Serum Amyloid A and Lipid Metabolism in Idiopathic Pulmonary Fibrosis: A New Target for Antifibrotic Therapy? 19
Totale 6.224
Categoria #
all - tutte 19.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022325 20 52 35 26 8 5 14 11 12 47 33 62
2022/2023466 25 52 35 40 27 79 31 57 53 30 30 7
2023/2024589 21 22 63 10 17 142 152 28 4 14 18 98
2024/20251.116 99 50 115 55 132 45 42 50 89 58 123 258
2025/20262.835 219 369 294 361 569 112 282 126 120 205 116 62
Totale 6.224